Clinical trial

Plegridy Observational Program

NCT02230969

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-11-12

PhaseN/A

Study timeline

Study start (actual)2014-11-12Date precision: day

Registry last updated2022-09-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing Forms of Multiple Sclerosisunresolved

Interventions

peginterferon beta-1aDRUG · verified · RxNorm: peginterferon beta-1a

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

BerlinGermany3 RomaItaly3 Washington D.C.District of Columbia, United States2 Oklahoma CityOklahoma, United States2 HamburgGermany2 SevilleSpain2 DaytonOhio, United States2 New YorkNew York, United States1 BostonMassachusetts, United States1 St LouisMissouri, United States1 AtlantaGeorgia, United States1 TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02230969 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.